We are live on ! Find out more
IBIO icon

iBio
IBIO

28 hedge funds and large institutions have $3.24M invested in iBio in 2020 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 8 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

886% more capital invested

Capital invested by funds: $329K → $3.24M (+$2.91M)

700% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 1

280% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 5

75% more funds holding

Funds holding: 16 → 28 (+12)

0% less ownership

Funds ownership: 0.01% → 0.01% (-0%)

Holders
28
Holders Change
+12
Holders Change %
+75%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
8
Reduced
1
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$647K
2
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans
Minnesota
+$245K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$224K
4
Jane Street
Jane Street
New York
+$77K
5
Goldman Sachs
Goldman Sachs
New York
+$74.7K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$75.4K
2
Citadel Advisors
Citadel Advisors
Florida
-$29K
3
Creative Planning
Creative Planning
Kansas
-$9K
4
PFGIA
Patriot Financial Group Insurance Agency
Massachusetts
-$7.7K
5
Barclays
Barclays
United Kingdom
-$7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.01M +$647K +1,682 +779%
BlackRock
2
BlackRock
New York
$872K +$68.5K +178 +12%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$344K +$224K +581 +842%
Thrivent Financial for Lutherans
4
Thrivent Financial for Lutherans
Minnesota
$337K +$245K +636 New
Jane Street
5
Jane Street
New York
$106K +$77K +200 New
Goldman Sachs
6
Goldman Sachs
New York
$103K +$74.7K +194 New
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
$92K +$66.6K +173 New
Millennium Management
8
Millennium Management
New York
$92K +$67K +174 New
Northern Trust
9
Northern Trust
Illinois
$69K +$38.9K +101 +348%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$49K +$35.8K +93 New
ECM
11
ExodusPoint Capital Management
New York
$42K +$21.9K +57 +259%
Renaissance Technologies
12
Renaissance Technologies
New York
$42K +$30.8K +80 New
Osaic Holdings
13
Osaic Holdings
Arizona
$25K +$18.9K +49 New
Bank of America
14
Bank of America
North Carolina
$21K +$7.31K +19 +90%
CAGAS
15
Capital Advisory Group Advisory Services
Minnesota
$11K +$7.7K +20 New
FWM
16
Frontier Wealth Management
Missouri
$11K +$7.7K +20 New
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
$6K +$3.08K +8 +200%
Morgan Stanley
18
Morgan Stanley
New York
$4K +$1.92K +5 +250%
PFO
19
Pathstone Family Office
New Jersey
$3K +$1.92K +5 New
LFG
20
Larson Financial Group
Missouri
$2K +$1.16K +3 New
PNC Financial Services Group
21
PNC Financial Services Group
Pennsylvania
$2K +$1.54K +4 New
AAP
22
Arax Advisory Partners
Colorado
$1K +$770 +2 New
SPIA
23
Steward Partners Investment Advisory
New York
$1K +$770 +2 New
Wells Fargo
24
Wells Fargo
California
$1K +$770 +2 New
AIC
25
Ameritas Investment Company
Nebraska
$1K +$1.16K +3 New
1
2

IBIO Hedge Fund Activity: Q1 2020 in Review

28 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q1 2020, worth a combined $3.24M — up 886% from $329K a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new IBIO positions and 5 closed out — a net gain of 14 holders — while 8 added to existing stakes and 1 trimmed.

The largest buyer was Vanguard Group, adding an estimated $647K. The largest seller was UBS Group, cutting an estimated $75.4K.

  • 28 institutional investors held iBio (IBIO) as of Q1 2020, up from 16 in Q4 2019.
  • Funds reported $3.24M of iBio stock for Q1 2020, up 886% quarter-over-quarter.
  • 19 funds opened new iBio positions in Q1 2020 and 5 closed out, a net change of +14 holders.
  • The largest iBio buyer in Q1 2020 was Vanguard Group, an estimated $647K added.
  • The largest iBio seller in Q1 2020 was UBS Group, an estimated $75.4K sold.

Based on aggregated 13F filings for Q1 2020.